Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001649553-25-000046·Annovis Bio, Inc.
Schedule 13G ownership disclosure
ANNOVIS BIO INC
Common Stock, par value $0.0001 per share · CUSIP: 03615A108
Event date: 2025-02-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CVI Investments, Inc.
Shares: 1,000,000 · Class: 5.1%
- Heights Capital Management, Inc.
Shares: 1,000,000 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001649553-25-000046
- Form type
- SCHEDULE 13G
- Filer
- Annovis Bio, Inc.
- CIK
- CIK 1477845
- Filed
- Feb 10, 2025
- Reporting period
- Feb 03, 2025
- Description
- Schedule 13G beneficial ownership